Organigram Global (OGI) Interest & Investment Income (2018 - 2021)

Organigram Global (OGI) posted quarterly Interest & Investment Income of -$432000.0 for Q2 2021, down 1185.35% year-on-year from $39802.9 in Q2 2020, and down 274.9% on a QoQ basis from $247000.0 in Q1 2021.

Organigram Global (OGI) Interest & Investment Income (2018 - 2021) Analysis & Trends

Organigram Global (OGI) has reported Interest & Investment Income for 4 consecutive years, with -$432000.0 the latest figure, recorded in Q2 2021.

  • Quarterly Interest & Investment Income fell 1185.35% year-over-year to -$432000.0 in Q2 2021, while the trailing twelve-month figure through May 2021 was -$173002.3 (down 126.03% YoY) and the FY2023 annual result came in at $3.0 million, changed N/A from the prior year.
  • Interest & Investment Income slipped to -$432000.0 in Q2 2021 per OGI's latest filing, from $247000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for OGI reached as high as $872879.5 in Q3 2019 and fell as low as -$578000.0 in Q2 2018.
  • A 4-year average of -$31542.6 and a median of -$74804.8 in 2020 frame the typical range for Interest & Investment Income.
  • The largest YoY upside for Interest & Investment Income was 252.47% in 2021 against a maximum downside of 1185.35% in 2021.
  • Year by year, Interest & Investment Income stood at -$578000.0 in 2018, then soared by 251.02% to $872879.5 in 2019, then sank by 113.29% to -$116000.0 in 2020, then slumped by 272.41% to -$432000.0 in 2021.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered -$432000.0, $247000.0, and -$116000.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 32.85 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 41.80 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 28.10 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Organigram Global 121.15 Mn 154.23 Mn 28.97 Mn -

Historic Data

Download Data
DateValue
May 31, 2021 -432,000.00
Feb 28, 2021 247,000.00
Nov 30, 2020 -116,000.00
Aug 31, 2020 127,997.72
May 31, 2020 -33,609.58
Feb 29, 2020 -162,000.00
Aug 31, 2019 872,879.50
May 31, 2019 -12,693.45
Feb 28, 2019 -229,000.00
May 31, 2018 -578,000.00